Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CalbaTech Seeks Majority Stake in Qicc

By HospiMedica staff writers
Posted on 18 Jul 2003
New terms that include an option for the future acquisition of majority ownership in Qicc, Ltd. More...
(Ayr, Scotland) have been negotiated by CalbaTech, Inc. (Irvine, CA, USA), which has been taking steps to begin to market Qicc's slide-based diagnostic products in North America.

CalbaTech's exclusive license with Qicc covers all of the company's manual products in North America as well as the development and distribution of an automated product in both North America and Japan. CalbaTech has recently begun its search for a strategic partner in Japan. The QiccStain immunohisochemistry reagents and kits of Qicc were recently cleared by the US Food and Drug Administration (FDA) under an exemption as a Class I device.

"We believe that current Qicc products will bring near term revenue and support Qicce's projected future products,” said James DeOlden, CEO of CalbaTech. "The potential of an acquisition was a key component in our agreement and it continues to enforce our belief in CalbaTech as a life sciences growth company.”

CalbaTech is focused on acquiring, incubating, and developing early-stage, life science based companies that are developing next-generation products and technologies, both in the United States and the United Kingdom.





Related Links:
Qicc
CalbaTech

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.